GLP-1 agonists like Ozempic activate glucagon-like peptide-1 receptors in the brain and gut, triggering satiety, reducing hunger hormones, and slowing gastric motility
it affected the brain via circumventricular organs and may work through select regions close to the ventricles, such as the LSc and ARH
However, previous clinical research has shown that patients gain back most of the weight lost with a GLP-1 when they stop taking the medication
Revisiting the cochlear and central mechanisms of tinnitus and therapeutic approaches
J Orthop Res 28:11551161 Chang C-H, Tsai W-C, Lin M-S, Hsu Y-H, Pang J-HS (2010) The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
The shorter half-life means liraglutide reaches stable blood levels much faster than semaglutide or tirzepatide